Gene Timothy Fass

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Crystalline hydrate of a JAK inhibitor compound
- Patent number 12,122,773
- Issue date Oct 22, 2024
- Theravance Biopharma R&D IP, LLC
- Gene Timothy Fass
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-...
- Patent number 11,718,591
- Issue date Aug 8, 2023
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 11,718,616
- Issue date Aug 8, 2023
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline hydrate of a JAK inhibitor compound
- Patent number 11,702,415
- Issue date Jul 18, 2023
- Theravance Biopharma R&D IP, LLC
- Gene Timothy Fass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for preparing JAK inhibitors and intermediates thereof
- Patent number 10,844,057
- Issue date Nov 24, 2020
- Theravance Biopharma R&D IP, LLC
- Pierre-Jean Colson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-...
- Patent number 10,752,599
- Issue date Aug 25, 2020
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(...
- Patent number 10,100,021
- Issue date Oct 16, 2018
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing biphenyl imidazole compounds
- Patent number 8,889,882
- Issue date Nov 18, 2014
- Theravance Biopharma R&D IP, LLC
- Weijiang Zhang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...
- Publication number 20240327360
- Publication date Oct 3, 2024
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE HYDRATE OF A JAK INHIBITOR COMPOUND
- Publication number 20240025897
- Publication date Jan 25, 2024
- THERAVANCE BIOPHARMA R&D IP, LLC
- Gene Timothy Fass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE
- Publication number 20220306624
- Publication date Sep 29, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...
- Publication number 20220242836
- Publication date Aug 4, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE HYDRATE OF A JAK INHIBITOR COMPOUND
- Publication number 20210269437
- Publication date Sep 2, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Gene Timothy Fass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...
- Publication number 20200157061
- Publication date May 21, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARING JAK INHIBITORS AND INTERMEDIATES THEREOF
- Publication number 20200071324
- Publication date Mar 5, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Pierre-Jean Colson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE(2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENY]-4-YL)-2-(E...
- Publication number 20170275259
- Publication date Sep 28, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20170121327
- Publication date May 4, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARING BIPHENYL IMIDAZOLE COMPOUNDS
- Publication number 20150038725
- Publication date Feb 5, 2015
- THERAVANCE BIOPHARMA R&D IP, LLC
- Weijiang Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARING BIPHENYL IMIDAZOLE COMPOUNDS
- Publication number 20130345437
- Publication date Dec 26, 2013
- Theravance, Inc.
- Weijiang Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARING BIPHENYL IMIDAZOLE COMPOUNDS
- Publication number 20110077411
- Publication date Mar 31, 2011
- Weijiang Zhang
- C07 - ORGANIC CHEMISTRY

Gene Timothy Fass

Person

Patents Grantslast 30 patents

Crystalline hydrate of a JAK inhibitor compound

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-...

JAK kinase inhibitor compounds for treatment of respiratory disease

Crystalline hydrate of a JAK inhibitor compound

Process for preparing JAK inhibitors and intermediates thereof

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-...

Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(...

Process for preparing biphenyl imidazole compounds

Patents Applicationslast 30 patents

CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...

CRYSTALLINE HYDRATE OF A JAK INHIBITOR COMPOUND

JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE

CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...

CRYSTALLINE HYDRATE OF A JAK INHIBITOR COMPOUND

CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...

PROCESS FOR PREPARING JAK INHIBITORS AND INTERMEDIATES THEREOF

CRYSTALLINE(2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENY]-4-YL)-2-(E...

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

PROCESS FOR PREPARING BIPHENYL IMIDAZOLE COMPOUNDS

PROCESS FOR PREPARING BIPHENYL IMIDAZOLE COMPOUNDS

PROCESS FOR PREPARING BIPHENYL IMIDAZOLE COMPOUNDS